{"author":{"id":"MDQ6VXNlcjEzMzMwOTE3","is_bot":false,"login":"timb-machine","name":"Tim Brown"},"body":"### Area\n\nMalware reports\n\n### Parent threat\n\n_No response_\n\n### Finding\n\nhttps://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development.pdf\n\n### Industry reference\n\nWellMail (APT29)\n\n### Malware reference\n\n_No response_\n\n### Actor reference\n\n_No response_\n\n### Component\n\n_No response_\n\n### Scenario\n\n_No response_\n\n","closed":false,"createdAt":"2022-04-20T10:30:11Z","labels":[{"id":"LA_kwDOFx8IA87xeZo8","name":"new","description":"","color":"fbca04"},{"id":"LA_kwDOFx8IA88AAAABGJHIzA","name":"missing:tactics","description":"","color":"bfd4f2"},{"id":"LA_kwDOFx8IA88AAAABIIpHQQ","name":"missing:tag:T1048","description":"","color":"FBCA04"},{"id":"LA_kwDOFx8IA88AAAABIIpHxw","name":"missing:tag:T1057","description":"","color":"BFDADC"},{"id":"LA_kwDOFx8IA88AAAABIIpJtA","name":"missing:tag:T1071.001","description":"","color":"FEF2C0"},{"id":"LA_kwDOFx8IA88AAAABIIpLIQ","name":"missing:tag:T1491","description":"","color":"1D76DB"},{"id":"LA_kwDOFx8IA88AAAABIIpMvQ","name":"missing:tag:T1567","description":"","color":"FEF2C0"},{"id":"LA_kwDOFx8IA88AAAABIIpNVg","name":"missing:tag:T1573","description":"","color":"006B75"},{"id":"LA_kwDOFx8IA88AAAABIIpNsg","name":"missing:tag:T1590","description":"","color":"FEF2C0"},{"id":"LA_kwDOFx8IA88AAAABIIpOww","name":"missing:tag:T1021.002","description":"","color":"006B75"},{"id":"LA_kwDOFx8IA88AAAABIIxX3w","name":"missing:tag:T1001","description":"","color":"006B75"},{"id":"LA_kwDOFx8IA88AAAABS-M7DQ","name":"missing:tag:wltm","description":"","color":"0052CC"}],"number":345,"title":"[Intel]: https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development.pdf"}
